This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1982 Jan-Feb;7(1):1-22.

doi: 10.2165/00003088-198207010-00001.

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

PMID: 7042170
DOI: 10.2165/00003088-198207010-00001

Review

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

M Eichelbaum. Clin Pharmacokinet. 1982 Jan-Feb.

. 1982 Jan-Feb;7(1):1-22.

doi: 10.2165/00003088-198207010-00001.

Author

PMID: 7042170
DOI: 10.2165/00003088-198207010-00001

No abstract available

PubMed Disclaimer

Similar articles

Polymorphic drug oxidation in humans.
Eichelbaum M. Eichelbaum M. Fed Proc. 1984 May 15;43(8):2298-302. Fed Proc. 1984. PMID: 6714436
[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
Eichelbaum M. Eichelbaum M. Internist (Berl). 1983 Mar;24(3):117-27. Internist (Berl). 1983. PMID: 6135670 Review. German. No abstract available.
Genetic polymorphism of drug metabolism in humans.
Gross AS, Kroemer HK, Eichelbaum M. Gross AS, et al. Adv Exp Med Biol. 1991;283:627-40. doi: 10.1007/978-1-4684-5877-0_79. Adv Exp Med Biol. 1991. PMID: 2069031 Review. No abstract available.
Genetically determined polymorphisms in drug oxidation.
Jacqz E, Hall SD, Branch RA. Jacqz E, et al. Hepatology. 1986 Sep-Oct;6(5):1020-32. doi: 10.1002/hep.1840060534. Hepatology. 1986. PMID: 3758933 No abstract available.
Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.
Idle JR, Smith RL. Idle JR, et al. Drug Metab Rev. 1979;9(2):301-17. doi: 10.3109/03602537908993896. Drug Metab Rev. 1979. PMID: 158499 Review. No abstract available.

See all similar articles

Cited by

Debrisoquine oxidative phenotyping and psychiatric drug treatment.
Derenne F, Joanne C, Vandel S, Bertschy G, Volmat R, Bechtel P. Derenne F, et al. Eur J Clin Pharmacol. 1989;36(1):53-8. doi: 10.1007/BF00561023. Eur J Clin Pharmacol. 1989. PMID: 2563689
Assessment of methods to identify sources of interindividual pharmacokinetic variations.
Vesell ES, Penno MB. Vesell ES, et al. Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409. doi: 10.2165/00003088-198308050-00002. Clin Pharmacokinet. 1983. PMID: 6194927 Review.
Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.
Coutts RT. Coutts RT. J Psychiatry Neurosci. 1994 Jan;19(1):30-44. J Psychiatry Neurosci. 1994. PMID: 8148364 Free PMC article. Review.
The influence of enzyme induction on polymorphic sparteine oxidation.
Eichelbaum M, Mineshita S, Ohnhaus EE, Zekorn C. Eichelbaum M, et al. Br J Clin Pharmacol. 1986 Jul;22(1):49-53. doi: 10.1111/j.1365-2125.1986.tb02879.x. Br J Clin Pharmacol. 1986. PMID: 3741726 Free PMC article.
Determination of debrisoquine metabolic ratio from hourly urine collections in healthy volunteers.
Philip PA, James CA, Rogers HJ. Philip PA, et al. Br J Clin Pharmacol. 1987 Dec;24(6):827-9. doi: 10.1111/j.1365-2125.1987.tb03254.x. Br J Clin Pharmacol. 1987. PMID: 3440103 Free PMC article.

See all "Cited by" articles

References

1. Eur J Clin Pharmacol. 1979 Sep;16(3):183-7 - PubMed
1. Br Med J. 1978 Jan 21;1(6106):142-4 - PubMed
1. Lancet. 1974 Mar 23;1(7856):475-7 - PubMed
1. Am J Med. 1979 Feb;66(2):183-7 - PubMed
1. Clin Pharmacol Ther. 1977 Feb;21(2):166-76 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information